Akili, Inc. (AKLI) Research

Akili, Inc. is a digital medicine enterprise focused on developing innovative digital therapies for individuals experiencing cognitive impairments. Its flagship product, EndeavorRx, stands out as a unique video game-based treatment that necessitates a physician's prescription and is specifically engineered to directly target and improve cognitive functioning. This company operates from its headquarters in Boston, Massachusetts.

Market snapshot

Symbol
AKLI
Price
$0.43
Day change
+0.25%
Market cap
$34.1M
P/E ratio
-0.57x
52-week range
0.1912-1.25
Sector
Healthcare
Industry
Medical - Healthcare Information Services
Analyst price target
$3.25

Peer companies

  • Babylon Holdings Limited (BBLNF)
  • Carebook Technologies Inc. (CRBKF)
  • HealthBeacon plc (HBCNF)
  • Nurosene Health Inc. (MNNDF)
  • MSP Recovery, Inc. (MSPR)
  • Renalytix Plc (RTNXF)
  • Science 37 Holdings, Inc. (SNCE)
  • Streamline Health Solutions, Inc. (STRM)

Recent insider activity

  • PureTech Health plc — U-Tender (12527477 shares) on 2024-07-02
  • Palihapitiya Chamath — U-Tender (1900000 shares) on 2024-07-02
  • Temasek Holdings (Private) Ltd — U-Tender (10336425 shares) on 2024-07-02
  • Temasek Holdings (Private) Ltd — U-Tender (1172697 shares) on 2024-07-02
  • Franklin Matthew — U-Tender (7657 shares) on 2024-07-02

Open Akili, Inc. (AKLI) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.